Guillevin Loïc
AP-HP, hôpital Cochin, université Paris-Descartes, Sorbonne Paris Cité, service de médecine interne, Inserm 1016, 75014 Paris, France.
Presse Med. 2012 Oct;41(10):1024-30. doi: 10.1016/j.lpm.2012.06.008. Epub 2012 Aug 18.
Corticosteroids and, according to severity or vasculitis type, cytotoxic agents are prescribed to treat systemic necrotizing vasculitides. Usually, in most vasculitides, treatment is prescribed for at least 18 months. Treatment is able to obtain a remission in approximatively 90% of patients. Relapse rate is high. Cyclophosphamide is usually prescribed for a few months, and administered by pulses. A maintenance treatment is compulsory and comprises usually azathioprine and methotrexate. Biologics can be proposed as ad on therapy like intravenous immunoglobulins and anti-TNF. Rituximab, an anti-CD20 drug is as effective as cyclophosphamide. It can be also prescribed to maintain remission.
根据病情严重程度或血管炎类型,使用皮质类固醇和细胞毒性药物治疗系统性坏死性血管炎。通常,在大多数血管炎中,治疗至少需要18个月。治疗能够使约90%的患者病情缓解。复发率很高。环磷酰胺通常使用几个月,并采用脉冲给药。维持治疗是必需的,通常包括硫唑嘌呤和甲氨蝶呤。生物制剂可作为附加治疗,如静脉注射免疫球蛋白和抗TNF药物。抗CD20药物利妥昔单抗与环磷酰胺疗效相当。它也可用于维持缓解。